AMT-130 | m-entrepreneurship.com

Product Name :
AMT-130

Search keywords :
GDNF

drugId :
null

Target Vo:
Glial cell line-derived neurotrophic factors

Target Vo Short Name :
GDNF

Moa_Name:
Gene silencing

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Amsterdam Molecular Therapeutics

Active Company_Name :
Uniqure Biopharma Bv

Active Indication_Name:
Huntington Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LC3B Antibody
Aromatase Antibody
CEACAM1 Antibody: CEACAM1 Antibody is an unconjugated, approximately 120-150 kDa, rabbit-derived, anti-CEACAM1 monoclonal antibody. CEACAM1 Antibody can be used for: WB, IHC-P, ICC/IF, IP expriments in human background without labeling.

Author: Betaine hydrochloride

Related Posts